Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial otitis media: current vaccine development strategies.

Allan W Cripps1, Jennelle Kyd

  • 1Gadi Research Centre for Medical and Health Sciences, University of Canberra, Canberra, Australia. allan.cripps@canberra.edu.au

Immunology and Cell Biology
|January 22, 2003
PubMed
Summary

Otitis media, a common childhood illness, causes hearing loss and developmental issues. Developing an effective tribacterial vaccine requires identifying antigens and understanding immune responses against key bacteria.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut Microbiome and Metabolic and Immune Indices in Males with or without Evidence of Metabolic Dysregulation.

Journal of obesity & metabolic syndrome·2024
Same author

Assessment of a Multispecies Probiotic Supplement for Relief of Seasonal Allergic Rhinitis: A Randomized Double-Blind Placebo-Controlled Trial.

Journal of integrative and complementary medicine·2023
Same author

Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable <i>Haemophilus influenzae</i> Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children.

Frontiers in cellular and infection microbiology·2022
Same author

Predominant Bacterial and Viral Otopathogens Identified Within the Respiratory Tract and Middle Ear of Urban Australian Children Experiencing Otitis Media Are Diversely Distributed.

Frontiers in cellular and infection microbiology·2022
Same author

The impacts of faecal subsampling on microbial compositional profiling.

BMC research notes·2022
Same author

Nasal immune gene expression in response to azelastine and fluticasone propionate combination or monotherapy.

Immunity, inflammation and disease·2021

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Otitis media is a leading cause of medical visits for children under five, associated with significant morbidity, particularly hearing loss impacting speech and cognitive development.
  • The pathogenesis of otitis media is multifactorial, with viral and bacterial infections being primary contributors.
  • Common viral culprits include respiratory syncytial virus and influenza, while Streptococcus pneumoniae, non-typeable Haemophilus influenzae, and Moraxella catarrhalis are the most frequently isolated bacteria.

Purpose of the Study:

  • To review the current landscape of otitis media treatment and vaccine development.
  • To highlight the challenges and future directions for creating a tribacterial vaccine effective against the most common bacterial pathogens.
  • To emphasize the need for identifying specific vaccine antigens and understanding middle ear immune responses.

Related Experiment Videos

Main Methods:

  • Literature review of otitis media causes, complications, and treatment strategies.
  • Analysis of current vaccine development progress for Streptococcus pneumoniae, non-typeable Haemophilus influenzae, and Moraxella catarrhalis.
  • Discussion of immunological requirements for a protective middle ear response.

Main Results:

  • Existing vaccines for Streptococcus pneumoniae show limited efficacy against otitis media.
  • Progress in identifying vaccine antigens for non-typeable Haemophilus influenzae is advanced, but less so for Moraxella catarrhalis.
  • No human studies exist for non-typeable H. influenzae or M. catarrhalis vaccines, and tribacterial vaccine concepts require further testing.

Conclusions:

  • A successful vaccine for bacterial otitis media must target the three most common bacteria: S. pneumoniae, non-typeable H. influenzae, and M. catarrhalis.
  • Further research into vaccine antigens and middle ear immunology is crucial for developing a tribacterial vaccine.
  • The formulation of a tribacterial vaccine is contingent upon determining effective antigens and understanding induced immune responses.